ArticleIntestinal Failure (New York, N.Y.)
Perspectives of intestinal rehabilitation providers on the use of oral rehydration solutions for pediatric patients with short bowel syndrome.
Article in Intestinal Failure (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with short bowel syndrome (SBS) have a loss of absorptive bowel surface area and are at risk for dehydration. Oral rehydration solutions (ORS) promote intestinal fluid absorption and may be used to maintain adequate hydration. Currently, there are no standard ORS recommendations for children with SBS. The objectives of this study are to (1) characterize the ORS practice patterns of pediatric intestinal rehabilitation providers and (2) understand the perceived barriers to patient compliance. Methods: A survey was created with questions regarding provider details, current practice recommendations for ORS, and the factors affecting ORS compliance. The survey was distributed electronically to intestinal rehabilitation providers in North America. Results: 66 individuals with varying clinical roles from across North America completed the survey. Most respondents recommend Pedialyte® (60/66) and the second most commonly recommended ORS is the homemade World Health Organization (WHO) ORS recipe (31/66). Regardless of the type of ORS, the most common reasons identified for poor patient compliance are poor taste and cost, with taste being a greater issue for the homemade solutions and cost being a greater issue for the commercially available products. Insurance coverage for ORS is limited (only reported for Pedialyte® and Ceralyte®). Discussion: The recommended ORS products contain variable sodium concentrations and variable sugar sources. The effect of these alternative sugar sources on intestinal absorption in SBS is not yet fully understood. Improved insurance coverage for ORS should be considered as this is cited as a barrier to the use of ORS in pediatric SBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.